Global Minimal Residual Disease (MRD) Testing Supply, Demand and Key Producers, 2023-2029
The global Minimal Residual Disease (MRD) Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Minimal Residual Disease (MRD) Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Minimal Residual Disease (MRD) Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Minimal Residual Disease (MRD) Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Minimal Residual Disease (MRD) Testing total market, 2018-2029, (USD Million)
Global Minimal Residual Disease (MRD) Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Minimal Residual Disease (MRD) Testing total market, key domestic companies and share, (USD Million)
Global Minimal Residual Disease (MRD) Testing revenue by player and market share 2018-2023, (USD Million)
Global Minimal Residual Disease (MRD) Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Minimal Residual Disease (MRD) Testing total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Minimal Residual Disease (MRD) Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sysmex Corporation, Natera, Asuragen, Quest Diagnostics, Mission Bio, LabCorp, Guardant Health, NeoGenomics Laboratories and ARUP Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Minimal Residual Disease (MRD) Testing market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Minimal Residual Disease (MRD) Testing Market, By Region:
1. How big is the global Minimal Residual Disease (MRD) Testing market?
2. What is the demand of the global Minimal Residual Disease (MRD) Testing market?
3. What is the year over year growth of the global Minimal Residual Disease (MRD) Testing market?
4. What is the total value of the global Minimal Residual Disease (MRD) Testing market?
5. Who are the major players in the global Minimal Residual Disease (MRD) Testing market?
6. What are the growth factors driving the market demand?
This report studies the global Minimal Residual Disease (MRD) Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Minimal Residual Disease (MRD) Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Minimal Residual Disease (MRD) Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Minimal Residual Disease (MRD) Testing total market, 2018-2029, (USD Million)
Global Minimal Residual Disease (MRD) Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Minimal Residual Disease (MRD) Testing total market, key domestic companies and share, (USD Million)
Global Minimal Residual Disease (MRD) Testing revenue by player and market share 2018-2023, (USD Million)
Global Minimal Residual Disease (MRD) Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Minimal Residual Disease (MRD) Testing total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Minimal Residual Disease (MRD) Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sysmex Corporation, Natera, Asuragen, Quest Diagnostics, Mission Bio, LabCorp, Guardant Health, NeoGenomics Laboratories and ARUP Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Minimal Residual Disease (MRD) Testing market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Minimal Residual Disease (MRD) Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Flow Cytometry
- Polymerase Chain Reaction
- Next-generation Sequencing
- Liquid Biopsies
- Specialty Clinics
- Hospitals
- Research Institutions
- Sysmex Corporation
- Natera
- Asuragen
- Quest Diagnostics
- Mission Bio
- LabCorp
- Guardant Health
- NeoGenomics Laboratories
- ARUP Laboratories
- NeoGenomics , Inc
- Opko Health
- Bio-Rad Laboratories
1. How big is the global Minimal Residual Disease (MRD) Testing market?
2. What is the demand of the global Minimal Residual Disease (MRD) Testing market?
3. What is the year over year growth of the global Minimal Residual Disease (MRD) Testing market?
4. What is the total value of the global Minimal Residual Disease (MRD) Testing market?
5. Who are the major players in the global Minimal Residual Disease (MRD) Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Minimal Residual Disease (MRD) Testing Introduction
1.2 World Minimal Residual Disease (MRD) Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Minimal Residual Disease (MRD) Testing Total Market by Region (by Headquarter Location)
1.3.1 World Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.3 China Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.4 Europe Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.5 Japan Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.6 South Korea Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.7 ASEAN Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.8 India Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Minimal Residual Disease (MRD) Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Minimal Residual Disease (MRD) Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.2 World Minimal Residual Disease (MRD) Testing Consumption Value by Region
2.2.1 World Minimal Residual Disease (MRD) Testing Consumption Value by Region (2018-2023)
2.2.2 World Minimal Residual Disease (MRD) Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.4 China Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.5 Europe Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.6 Japan Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.7 South Korea Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.8 ASEAN Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.9 India Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
3 WORLD MINIMAL RESIDUAL DISEASE (MRD) TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Minimal Residual Disease (MRD) Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Minimal Residual Disease (MRD) Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Minimal Residual Disease (MRD) Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Minimal Residual Disease (MRD) Testing in 2022
3.3 Minimal Residual Disease (MRD) Testing Company Evaluation Quadrant
3.4 Minimal Residual Disease (MRD) Testing Market: Overall Company Footprint Analysis
3.4.1 Minimal Residual Disease (MRD) Testing Market: Region Footprint
3.4.2 Minimal Residual Disease (MRD) Testing Market: Company Product Type Footprint
3.4.3 Minimal Residual Disease (MRD) Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Minimal Residual Disease (MRD) Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Minimal Residual Disease (MRD) Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Minimal Residual Disease (MRD) Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Minimal Residual Disease (MRD) Testing Consumption Value Comparison
4.2.1 United States VS China: Minimal Residual Disease (MRD) Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Minimal Residual Disease (MRD) Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Minimal Residual Disease (MRD) Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Minimal Residual Disease (MRD) Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023)
4.4 China Based Companies Minimal Residual Disease (MRD) Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Minimal Residual Disease (MRD) Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023)
4.5 Rest of World Based Minimal Residual Disease (MRD) Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Minimal Residual Disease (MRD) Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Minimal Residual Disease (MRD) Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Flow Cytometry
5.2.2 Polymerase Chain Reaction
5.2.3 Next-generation Sequencing
5.2.4 Liquid Biopsies
5.3 Market Segment by Type
5.3.1 World Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023)
5.3.2 World Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2029)
5.3.3 World Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Minimal Residual Disease (MRD) Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Specialty Clinics
6.2.2 Hospitals
6.2.3 Research Institutions
6.3 Market Segment by Application
6.3.1 World Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023)
6.3.2 World Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2029)
6.3.3 World Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sysmex Corporation
7.1.1 Sysmex Corporation Details
7.1.2 Sysmex Corporation Major Business
7.1.3 Sysmex Corporation Minimal Residual Disease (MRD) Testing Product and Services
7.1.4 Sysmex Corporation Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Sysmex Corporation Recent Developments/Updates
7.1.6 Sysmex Corporation Competitive Strengths & Weaknesses
7.2 Natera
7.2.1 Natera Details
7.2.2 Natera Major Business
7.2.3 Natera Minimal Residual Disease (MRD) Testing Product and Services
7.2.4 Natera Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Natera Recent Developments/Updates
7.2.6 Natera Competitive Strengths & Weaknesses
7.3 Asuragen
7.3.1 Asuragen Details
7.3.2 Asuragen Major Business
7.3.3 Asuragen Minimal Residual Disease (MRD) Testing Product and Services
7.3.4 Asuragen Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Asuragen Recent Developments/Updates
7.3.6 Asuragen Competitive Strengths & Weaknesses
7.4 Quest Diagnostics
7.4.1 Quest Diagnostics Details
7.4.2 Quest Diagnostics Major Business
7.4.3 Quest Diagnostics Minimal Residual Disease (MRD) Testing Product and Services
7.4.4 Quest Diagnostics Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Quest Diagnostics Recent Developments/Updates
7.4.6 Quest Diagnostics Competitive Strengths & Weaknesses
7.5 Mission Bio
7.5.1 Mission Bio Details
7.5.2 Mission Bio Major Business
7.5.3 Mission Bio Minimal Residual Disease (MRD) Testing Product and Services
7.5.4 Mission Bio Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Mission Bio Recent Developments/Updates
7.5.6 Mission Bio Competitive Strengths & Weaknesses
7.6 LabCorp
7.6.1 LabCorp Details
7.6.2 LabCorp Major Business
7.6.3 LabCorp Minimal Residual Disease (MRD) Testing Product and Services
7.6.4 LabCorp Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 LabCorp Recent Developments/Updates
7.6.6 LabCorp Competitive Strengths & Weaknesses
7.7 Guardant Health
7.7.1 Guardant Health Details
7.7.2 Guardant Health Major Business
7.7.3 Guardant Health Minimal Residual Disease (MRD) Testing Product and Services
7.7.4 Guardant Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Guardant Health Recent Developments/Updates
7.7.6 Guardant Health Competitive Strengths & Weaknesses
7.8 NeoGenomics Laboratories
7.8.1 NeoGenomics Laboratories Details
7.8.2 NeoGenomics Laboratories Major Business
7.8.3 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product and Services
7.8.4 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 NeoGenomics Laboratories Recent Developments/Updates
7.8.6 NeoGenomics Laboratories Competitive Strengths & Weaknesses
7.9 ARUP Laboratories
7.9.1 ARUP Laboratories Details
7.9.2 ARUP Laboratories Major Business
7.9.3 ARUP Laboratories Minimal Residual Disease (MRD) Testing Product and Services
7.9.4 ARUP Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 ARUP Laboratories Recent Developments/Updates
7.9.6 ARUP Laboratories Competitive Strengths & Weaknesses
7.10 NeoGenomics , Inc
7.10.1 NeoGenomics , Inc Details
7.10.2 NeoGenomics , Inc Major Business
7.10.3 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product and Services
7.10.4 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 NeoGenomics , Inc Recent Developments/Updates
7.10.6 NeoGenomics , Inc Competitive Strengths & Weaknesses
7.11 Opko Health
7.11.1 Opko Health Details
7.11.2 Opko Health Major Business
7.11.3 Opko Health Minimal Residual Disease (MRD) Testing Product and Services
7.11.4 Opko Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Opko Health Recent Developments/Updates
7.11.6 Opko Health Competitive Strengths & Weaknesses
7.12 Bio-Rad Laboratories
7.12.1 Bio-Rad Laboratories Details
7.12.2 Bio-Rad Laboratories Major Business
7.12.3 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product and Services
7.12.4 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Bio-Rad Laboratories Recent Developments/Updates
7.12.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Minimal Residual Disease (MRD) Testing Industry Chain
8.2 Minimal Residual Disease (MRD) Testing Upstream Analysis
8.3 Minimal Residual Disease (MRD) Testing Midstream Analysis
8.4 Minimal Residual Disease (MRD) Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Minimal Residual Disease (MRD) Testing Introduction
1.2 World Minimal Residual Disease (MRD) Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Minimal Residual Disease (MRD) Testing Total Market by Region (by Headquarter Location)
1.3.1 World Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.3 China Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.4 Europe Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.5 Japan Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.6 South Korea Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.7 ASEAN Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.3.8 India Minimal Residual Disease (MRD) Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Minimal Residual Disease (MRD) Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Minimal Residual Disease (MRD) Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.2 World Minimal Residual Disease (MRD) Testing Consumption Value by Region
2.2.1 World Minimal Residual Disease (MRD) Testing Consumption Value by Region (2018-2023)
2.2.2 World Minimal Residual Disease (MRD) Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.4 China Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.5 Europe Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.6 Japan Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.7 South Korea Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.8 ASEAN Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
2.9 India Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029)
3 WORLD MINIMAL RESIDUAL DISEASE (MRD) TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Minimal Residual Disease (MRD) Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Minimal Residual Disease (MRD) Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Minimal Residual Disease (MRD) Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Minimal Residual Disease (MRD) Testing in 2022
3.3 Minimal Residual Disease (MRD) Testing Company Evaluation Quadrant
3.4 Minimal Residual Disease (MRD) Testing Market: Overall Company Footprint Analysis
3.4.1 Minimal Residual Disease (MRD) Testing Market: Region Footprint
3.4.2 Minimal Residual Disease (MRD) Testing Market: Company Product Type Footprint
3.4.3 Minimal Residual Disease (MRD) Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Minimal Residual Disease (MRD) Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Minimal Residual Disease (MRD) Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Minimal Residual Disease (MRD) Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Minimal Residual Disease (MRD) Testing Consumption Value Comparison
4.2.1 United States VS China: Minimal Residual Disease (MRD) Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Minimal Residual Disease (MRD) Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Minimal Residual Disease (MRD) Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Minimal Residual Disease (MRD) Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023)
4.4 China Based Companies Minimal Residual Disease (MRD) Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Minimal Residual Disease (MRD) Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023)
4.5 Rest of World Based Minimal Residual Disease (MRD) Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Minimal Residual Disease (MRD) Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Minimal Residual Disease (MRD) Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Flow Cytometry
5.2.2 Polymerase Chain Reaction
5.2.3 Next-generation Sequencing
5.2.4 Liquid Biopsies
5.3 Market Segment by Type
5.3.1 World Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023)
5.3.2 World Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2029)
5.3.3 World Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Minimal Residual Disease (MRD) Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Specialty Clinics
6.2.2 Hospitals
6.2.3 Research Institutions
6.3 Market Segment by Application
6.3.1 World Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023)
6.3.2 World Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2029)
6.3.3 World Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sysmex Corporation
7.1.1 Sysmex Corporation Details
7.1.2 Sysmex Corporation Major Business
7.1.3 Sysmex Corporation Minimal Residual Disease (MRD) Testing Product and Services
7.1.4 Sysmex Corporation Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Sysmex Corporation Recent Developments/Updates
7.1.6 Sysmex Corporation Competitive Strengths & Weaknesses
7.2 Natera
7.2.1 Natera Details
7.2.2 Natera Major Business
7.2.3 Natera Minimal Residual Disease (MRD) Testing Product and Services
7.2.4 Natera Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Natera Recent Developments/Updates
7.2.6 Natera Competitive Strengths & Weaknesses
7.3 Asuragen
7.3.1 Asuragen Details
7.3.2 Asuragen Major Business
7.3.3 Asuragen Minimal Residual Disease (MRD) Testing Product and Services
7.3.4 Asuragen Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Asuragen Recent Developments/Updates
7.3.6 Asuragen Competitive Strengths & Weaknesses
7.4 Quest Diagnostics
7.4.1 Quest Diagnostics Details
7.4.2 Quest Diagnostics Major Business
7.4.3 Quest Diagnostics Minimal Residual Disease (MRD) Testing Product and Services
7.4.4 Quest Diagnostics Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Quest Diagnostics Recent Developments/Updates
7.4.6 Quest Diagnostics Competitive Strengths & Weaknesses
7.5 Mission Bio
7.5.1 Mission Bio Details
7.5.2 Mission Bio Major Business
7.5.3 Mission Bio Minimal Residual Disease (MRD) Testing Product and Services
7.5.4 Mission Bio Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Mission Bio Recent Developments/Updates
7.5.6 Mission Bio Competitive Strengths & Weaknesses
7.6 LabCorp
7.6.1 LabCorp Details
7.6.2 LabCorp Major Business
7.6.3 LabCorp Minimal Residual Disease (MRD) Testing Product and Services
7.6.4 LabCorp Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 LabCorp Recent Developments/Updates
7.6.6 LabCorp Competitive Strengths & Weaknesses
7.7 Guardant Health
7.7.1 Guardant Health Details
7.7.2 Guardant Health Major Business
7.7.3 Guardant Health Minimal Residual Disease (MRD) Testing Product and Services
7.7.4 Guardant Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Guardant Health Recent Developments/Updates
7.7.6 Guardant Health Competitive Strengths & Weaknesses
7.8 NeoGenomics Laboratories
7.8.1 NeoGenomics Laboratories Details
7.8.2 NeoGenomics Laboratories Major Business
7.8.3 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product and Services
7.8.4 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 NeoGenomics Laboratories Recent Developments/Updates
7.8.6 NeoGenomics Laboratories Competitive Strengths & Weaknesses
7.9 ARUP Laboratories
7.9.1 ARUP Laboratories Details
7.9.2 ARUP Laboratories Major Business
7.9.3 ARUP Laboratories Minimal Residual Disease (MRD) Testing Product and Services
7.9.4 ARUP Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 ARUP Laboratories Recent Developments/Updates
7.9.6 ARUP Laboratories Competitive Strengths & Weaknesses
7.10 NeoGenomics , Inc
7.10.1 NeoGenomics , Inc Details
7.10.2 NeoGenomics , Inc Major Business
7.10.3 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product and Services
7.10.4 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 NeoGenomics , Inc Recent Developments/Updates
7.10.6 NeoGenomics , Inc Competitive Strengths & Weaknesses
7.11 Opko Health
7.11.1 Opko Health Details
7.11.2 Opko Health Major Business
7.11.3 Opko Health Minimal Residual Disease (MRD) Testing Product and Services
7.11.4 Opko Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Opko Health Recent Developments/Updates
7.11.6 Opko Health Competitive Strengths & Weaknesses
7.12 Bio-Rad Laboratories
7.12.1 Bio-Rad Laboratories Details
7.12.2 Bio-Rad Laboratories Major Business
7.12.3 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product and Services
7.12.4 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Bio-Rad Laboratories Recent Developments/Updates
7.12.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Minimal Residual Disease (MRD) Testing Industry Chain
8.2 Minimal Residual Disease (MRD) Testing Upstream Analysis
8.3 Minimal Residual Disease (MRD) Testing Midstream Analysis
8.4 Minimal Residual Disease (MRD) Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Minimal Residual Disease (MRD) Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Minimal Residual Disease (MRD) Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Minimal Residual Disease (MRD) Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Minimal Residual Disease (MRD) Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Minimal Residual Disease (MRD) Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Minimal Residual Disease (MRD) Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Minimal Residual Disease (MRD) Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Minimal Residual Disease (MRD) Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Minimal Residual Disease (MRD) Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Minimal Residual Disease (MRD) Testing Players in 2022
Table 12. World Minimal Residual Disease (MRD) Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Minimal Residual Disease (MRD) Testing Company Evaluation Quadrant
Table 14. Head Office of Key Minimal Residual Disease (MRD) Testing Player
Table 15. Minimal Residual Disease (MRD) Testing Market: Company Product Type Footprint
Table 16. Minimal Residual Disease (MRD) Testing Market: Company Product Application Footprint
Table 17. Minimal Residual Disease (MRD) Testing Mergers & Acquisitions Activity
Table 18. United States VS China Minimal Residual Disease (MRD) Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Minimal Residual Disease (MRD) Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Minimal Residual Disease (MRD) Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Minimal Residual Disease (MRD) Testing Revenue Market Share (2018-2023)
Table 23. China Based Minimal Residual Disease (MRD) Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Minimal Residual Disease (MRD) Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Minimal Residual Disease (MRD) Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Minimal Residual Disease (MRD) Testing Revenue Market Share (2018-2023)
Table 29. World Minimal Residual Disease (MRD) Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Minimal Residual Disease (MRD) Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Sysmex Corporation Basic Information, Area Served and Competitors
Table 36. Sysmex Corporation Major Business
Table 37. Sysmex Corporation Minimal Residual Disease (MRD) Testing Product and Services
Table 38. Sysmex Corporation Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Sysmex Corporation Recent Developments/Updates
Table 40. Sysmex Corporation Competitive Strengths & Weaknesses
Table 41. Natera Basic Information, Area Served and Competitors
Table 42. Natera Major Business
Table 43. Natera Minimal Residual Disease (MRD) Testing Product and Services
Table 44. Natera Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Natera Recent Developments/Updates
Table 46. Natera Competitive Strengths & Weaknesses
Table 47. Asuragen Basic Information, Area Served and Competitors
Table 48. Asuragen Major Business
Table 49. Asuragen Minimal Residual Disease (MRD) Testing Product and Services
Table 50. Asuragen Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Asuragen Recent Developments/Updates
Table 52. Asuragen Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Basic Information, Area Served and Competitors
Table 54. Quest Diagnostics Major Business
Table 55. Quest Diagnostics Minimal Residual Disease (MRD) Testing Product and Services
Table 56. Quest Diagnostics Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
Table 59. Mission Bio Basic Information, Area Served and Competitors
Table 60. Mission Bio Major Business
Table 61. Mission Bio Minimal Residual Disease (MRD) Testing Product and Services
Table 62. Mission Bio Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Mission Bio Recent Developments/Updates
Table 64. Mission Bio Competitive Strengths & Weaknesses
Table 65. LabCorp Basic Information, Area Served and Competitors
Table 66. LabCorp Major Business
Table 67. LabCorp Minimal Residual Disease (MRD) Testing Product and Services
Table 68. LabCorp Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. LabCorp Recent Developments/Updates
Table 70. LabCorp Competitive Strengths & Weaknesses
Table 71. Guardant Health Basic Information, Area Served and Competitors
Table 72. Guardant Health Major Business
Table 73. Guardant Health Minimal Residual Disease (MRD) Testing Product and Services
Table 74. Guardant Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Guardant Health Recent Developments/Updates
Table 76. Guardant Health Competitive Strengths & Weaknesses
Table 77. NeoGenomics Laboratories Basic Information, Area Served and Competitors
Table 78. NeoGenomics Laboratories Major Business
Table 79. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product and Services
Table 80. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. NeoGenomics Laboratories Recent Developments/Updates
Table 82. NeoGenomics Laboratories Competitive Strengths & Weaknesses
Table 83. ARUP Laboratories Basic Information, Area Served and Competitors
Table 84. ARUP Laboratories Major Business
Table 85. ARUP Laboratories Minimal Residual Disease (MRD) Testing Product and Services
Table 86. ARUP Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. ARUP Laboratories Recent Developments/Updates
Table 88. ARUP Laboratories Competitive Strengths & Weaknesses
Table 89. NeoGenomics , Inc Basic Information, Area Served and Competitors
Table 90. NeoGenomics , Inc Major Business
Table 91. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product and Services
Table 92. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. NeoGenomics , Inc Recent Developments/Updates
Table 94. NeoGenomics , Inc Competitive Strengths & Weaknesses
Table 95. Opko Health Basic Information, Area Served and Competitors
Table 96. Opko Health Major Business
Table 97. Opko Health Minimal Residual Disease (MRD) Testing Product and Services
Table 98. Opko Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Opko Health Recent Developments/Updates
Table 100. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 101. Bio-Rad Laboratories Major Business
Table 102. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product and Services
Table 103. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Minimal Residual Disease (MRD) Testing Upstream (Raw Materials)
Table 105. Minimal Residual Disease (MRD) Testing Typical Customers
List of Figure
Figure 1. Minimal Residual Disease (MRD) Testing Picture
Figure 2. World Minimal Residual Disease (MRD) Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Minimal Residual Disease (MRD) Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Minimal Residual Disease (MRD) Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Minimal Residual Disease (MRD) Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 13. Minimal Residual Disease (MRD) Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Minimal Residual Disease (MRD) Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Minimal Residual Disease (MRD) Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Minimal Residual Disease (MRD) Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Minimal Residual Disease (MRD) Testing Markets in 2022
Figure 27. United States VS China: Minimal Residual Disease (MRD) Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Minimal Residual Disease (MRD) Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Minimal Residual Disease (MRD) Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Minimal Residual Disease (MRD) Testing Market Size Market Share by Type in 2022
Figure 31. Flow Cytometry
Figure 32. Polymerase Chain Reaction
Figure 33. Next-generation Sequencing
Figure 34. Liquid Biopsies
Figure 35. World Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2018-2029)
Figure 36. World Minimal Residual Disease (MRD) Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Minimal Residual Disease (MRD) Testing Market Size Market Share by Application in 2022
Figure 38. Specialty Clinics
Figure 39. Hospitals
Figure 40. Research Institutions
Figure 41. Minimal Residual Disease (MRD) Testing Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Table 1. World Minimal Residual Disease (MRD) Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Minimal Residual Disease (MRD) Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Minimal Residual Disease (MRD) Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Minimal Residual Disease (MRD) Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Minimal Residual Disease (MRD) Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Minimal Residual Disease (MRD) Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Minimal Residual Disease (MRD) Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Minimal Residual Disease (MRD) Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Minimal Residual Disease (MRD) Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Minimal Residual Disease (MRD) Testing Players in 2022
Table 12. World Minimal Residual Disease (MRD) Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Minimal Residual Disease (MRD) Testing Company Evaluation Quadrant
Table 14. Head Office of Key Minimal Residual Disease (MRD) Testing Player
Table 15. Minimal Residual Disease (MRD) Testing Market: Company Product Type Footprint
Table 16. Minimal Residual Disease (MRD) Testing Market: Company Product Application Footprint
Table 17. Minimal Residual Disease (MRD) Testing Mergers & Acquisitions Activity
Table 18. United States VS China Minimal Residual Disease (MRD) Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Minimal Residual Disease (MRD) Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Minimal Residual Disease (MRD) Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Minimal Residual Disease (MRD) Testing Revenue Market Share (2018-2023)
Table 23. China Based Minimal Residual Disease (MRD) Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Minimal Residual Disease (MRD) Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Minimal Residual Disease (MRD) Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Minimal Residual Disease (MRD) Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Minimal Residual Disease (MRD) Testing Revenue Market Share (2018-2023)
Table 29. World Minimal Residual Disease (MRD) Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Minimal Residual Disease (MRD) Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Minimal Residual Disease (MRD) Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Minimal Residual Disease (MRD) Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Sysmex Corporation Basic Information, Area Served and Competitors
Table 36. Sysmex Corporation Major Business
Table 37. Sysmex Corporation Minimal Residual Disease (MRD) Testing Product and Services
Table 38. Sysmex Corporation Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Sysmex Corporation Recent Developments/Updates
Table 40. Sysmex Corporation Competitive Strengths & Weaknesses
Table 41. Natera Basic Information, Area Served and Competitors
Table 42. Natera Major Business
Table 43. Natera Minimal Residual Disease (MRD) Testing Product and Services
Table 44. Natera Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Natera Recent Developments/Updates
Table 46. Natera Competitive Strengths & Weaknesses
Table 47. Asuragen Basic Information, Area Served and Competitors
Table 48. Asuragen Major Business
Table 49. Asuragen Minimal Residual Disease (MRD) Testing Product and Services
Table 50. Asuragen Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Asuragen Recent Developments/Updates
Table 52. Asuragen Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Basic Information, Area Served and Competitors
Table 54. Quest Diagnostics Major Business
Table 55. Quest Diagnostics Minimal Residual Disease (MRD) Testing Product and Services
Table 56. Quest Diagnostics Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
Table 59. Mission Bio Basic Information, Area Served and Competitors
Table 60. Mission Bio Major Business
Table 61. Mission Bio Minimal Residual Disease (MRD) Testing Product and Services
Table 62. Mission Bio Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Mission Bio Recent Developments/Updates
Table 64. Mission Bio Competitive Strengths & Weaknesses
Table 65. LabCorp Basic Information, Area Served and Competitors
Table 66. LabCorp Major Business
Table 67. LabCorp Minimal Residual Disease (MRD) Testing Product and Services
Table 68. LabCorp Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. LabCorp Recent Developments/Updates
Table 70. LabCorp Competitive Strengths & Weaknesses
Table 71. Guardant Health Basic Information, Area Served and Competitors
Table 72. Guardant Health Major Business
Table 73. Guardant Health Minimal Residual Disease (MRD) Testing Product and Services
Table 74. Guardant Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Guardant Health Recent Developments/Updates
Table 76. Guardant Health Competitive Strengths & Weaknesses
Table 77. NeoGenomics Laboratories Basic Information, Area Served and Competitors
Table 78. NeoGenomics Laboratories Major Business
Table 79. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Product and Services
Table 80. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. NeoGenomics Laboratories Recent Developments/Updates
Table 82. NeoGenomics Laboratories Competitive Strengths & Weaknesses
Table 83. ARUP Laboratories Basic Information, Area Served and Competitors
Table 84. ARUP Laboratories Major Business
Table 85. ARUP Laboratories Minimal Residual Disease (MRD) Testing Product and Services
Table 86. ARUP Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. ARUP Laboratories Recent Developments/Updates
Table 88. ARUP Laboratories Competitive Strengths & Weaknesses
Table 89. NeoGenomics , Inc Basic Information, Area Served and Competitors
Table 90. NeoGenomics , Inc Major Business
Table 91. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Product and Services
Table 92. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. NeoGenomics , Inc Recent Developments/Updates
Table 94. NeoGenomics , Inc Competitive Strengths & Weaknesses
Table 95. Opko Health Basic Information, Area Served and Competitors
Table 96. Opko Health Major Business
Table 97. Opko Health Minimal Residual Disease (MRD) Testing Product and Services
Table 98. Opko Health Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Opko Health Recent Developments/Updates
Table 100. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 101. Bio-Rad Laboratories Major Business
Table 102. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Product and Services
Table 103. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Minimal Residual Disease (MRD) Testing Upstream (Raw Materials)
Table 105. Minimal Residual Disease (MRD) Testing Typical Customers
List of Figure
Figure 1. Minimal Residual Disease (MRD) Testing Picture
Figure 2. World Minimal Residual Disease (MRD) Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Minimal Residual Disease (MRD) Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Minimal Residual Disease (MRD) Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Minimal Residual Disease (MRD) Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Minimal Residual Disease (MRD) Testing Revenue (2018-2029) & (USD Million)
Figure 13. Minimal Residual Disease (MRD) Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Minimal Residual Disease (MRD) Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Minimal Residual Disease (MRD) Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Minimal Residual Disease (MRD) Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Minimal Residual Disease (MRD) Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Minimal Residual Disease (MRD) Testing Markets in 2022
Figure 27. United States VS China: Minimal Residual Disease (MRD) Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Minimal Residual Disease (MRD) Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Minimal Residual Disease (MRD) Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Minimal Residual Disease (MRD) Testing Market Size Market Share by Type in 2022
Figure 31. Flow Cytometry
Figure 32. Polymerase Chain Reaction
Figure 33. Next-generation Sequencing
Figure 34. Liquid Biopsies
Figure 35. World Minimal Residual Disease (MRD) Testing Market Size Market Share by Type (2018-2029)
Figure 36. World Minimal Residual Disease (MRD) Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Minimal Residual Disease (MRD) Testing Market Size Market Share by Application in 2022
Figure 38. Specialty Clinics
Figure 39. Hospitals
Figure 40. Research Institutions
Figure 41. Minimal Residual Disease (MRD) Testing Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
